Hepta Medical

Aura Aero secures €50 million in funding, leading nine financing rounds totaling €86.5 million for French Tech startups between April 6 and April 10. Other funded companies include NeuroClues, Hepta Medical, and Cobl.ai, spanning sectors like fintech, healthcare, and AI.

Apr 2026The French Tech JournalNews article

Hepta Medical holds a U.S. patent for its microwave ablation probe, designed for minimally invasive treatment of early-stage lung cancer. The device enables precise thermal therapy during catheter-based procedures. The innovation targets improved accuracy in targeting tumors while reducing patient recovery time.

Oct 2024MedicalExpo e-MagazineNews article

HEPTA Medical secures €5.7 million in Series A funding, led by BPI France, to advance its microwave ablation platform designed for lung cancer treatment. The investment supports further development of the company’s technology, which targets minimally invasive therapeutic solutions. The platform aims to improve precision and efficacy in treating lung cancer patients.

Sep 2024Medical Device NetworkNews article

Hepta Medical secures €5.7 million in Series A funding to advance its thermal ablation therapy for early-stage lung cancer. The medical device company leverages the investment to further develop its treatment solutions targeting a critical patient segment. Goodwin Law’s Paris Life Sciences team facilitated the financing round.

Sep 2024goodwinlaw.comNews article